These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28215604)

  • 1. Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
    J Allergy Clin Immunol Pract; 2017; 5(4):1050-1060.e9. PubMed ID: 28215604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
    J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Eosinophil Count and Outcomes in Severe Uncontrolled Asthma: A Prospective Study.
    Zeiger RS; Schatz M; Dalal AA; Chen W; Sadikova E; Suruki RY; Kawatkar AA; Qian L
    J Allergy Clin Immunol Pract; 2017; 5(1):144-153.e8. PubMed ID: 27665383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Corticosteroid Prescribing for Children With Asthma in a Medicaid Managed Care Program.
    Farber HJ; Silveira EA; Vicere DR; Kothari VD; Giardino AP
    Pediatrics; 2017 May; 139(5):. PubMed ID: 28557753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Economic Burden of Severe Asthma With Low Blood Eosinophil Counts.
    Busby J; Menon S; Martin N; Lipworth J; Zhang R; Burhan H; Brown T; Chaudhuri R; Gore R; Jackson DJ; Naveed S; Pantin T; Pfeffer PE; Patel M; Patel PH; Rupani H; Heaney LG
    J Allergy Clin Immunol Pract; 2024 Oct; 12(10):2785-2797. PubMed ID: 39032830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of controller to total asthma medications: determinants of the measure.
    Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
    Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.
    Price DB; Rigazio A; Campbell JD; Bleecker ER; Corrigan CJ; Thomas M; Wenzel SE; Wilson AM; Small MB; Gopalan G; Ashton VL; Burden A; Hillyer EV; Kerkhof M; Pavord ID
    Lancet Respir Med; 2015 Nov; 3(11):849-58. PubMed ID: 26493938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization and Costs of Severe Uncontrolled Asthma in a Managed-Care Setting.
    Zeiger RS; Schatz M; Dalal AA; Qian L; Chen W; Ngor EW; Suruki RY; Kawatkar AA
    J Allergy Clin Immunol Pract; 2016; 4(1):120-9.e3. PubMed ID: 26439182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use.
    Zazzali JL; Broder MS; Omachi TA; Chang E; Sun GH; Raimundo K
    Allergy Asthma Proc; 2015; 36(4):268-74. PubMed ID: 26108084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma.
    Makhinova T; Barner JC; Richards KM; Rascati KL
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1124-32. PubMed ID: 26679962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and Outcomes of HEDIS-Defined Asthma Patients with COPD Diagnostic Coding.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
    J Allergy Clin Immunol Pract; 2016; 4(2):273-83.e5. PubMed ID: 26619923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients.
    Siergiejko Z; Świebocka E; Smith N; Peckitt C; Leo J; Peachey G; Maykut R
    Curr Med Res Opin; 2011 Nov; 27(11):2223-8. PubMed ID: 21933100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of oral corticosteroids in the treatment of acute wheezing episodes in asthmatic preschoolers: Systematic review with meta-analysis.
    Castro-Rodriguez JA; Beckhaus AA; Forno E
    Pediatr Pulmonol; 2016 Aug; 51(8):868-76. PubMed ID: 27074244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio.
    Luskin AT; Antonova EN; Broder MS; Chang E; Raimundo K; Solari PG
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1117-1124. PubMed ID: 29083971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Study on the Relationship of Obesity to Asthma Impairment and Risk.
    Schatz M; Zeiger RS; Yang SJ; Chen W; Sajjan S; Allen-Ramey F; Camargo CA
    J Allergy Clin Immunol Pract; 2015; 3(4):560-5.e1. PubMed ID: 25975622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time asthma outreach reduces excessive short-acting β2-agonist use: a randomized study.
    Zeiger RS; Schatz M; Li Q; Solari PG; Zazzali JL; Chen W
    J Allergy Clin Immunol Pract; 2014; 2(4):445-456, 456.e1-5. PubMed ID: 25017534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
    Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
    J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.